Paolo Grossi is Professor of Infectious Diseases at the School of Medicine University of Insubria, Varese, Italy. Since February 2001, he has been the Director of the Infectious and Tropical Diseases Unit of the ASST-Sette Laghi of Varese, Italy. Starting in 1999 he has been the advisor for all infectious diseases related problems at the Italian National Centre for Transplantation in Italy and covers the role of “second opinion” for all organ donors with potentially transmissible infectious diseases. He is the chair of the ESCMID Study Group on infections in Immunocompromised Host and the past Chair of the ID Council of ISHLT.
Dr. Forrest is currently a Professor of Medicine within the Division of Infectious Diseases at Rush University Medical Center, working with the Transplant Infectious Disease team.
He graduated from The University of Adelaide, Australia in 1990. His Internal Medicine Residency was at Columbus Hospital in Chicago, with Chief Resident year at St Joseph Hospital in Chicago. His Infectious Disease fellowship was at the University of Maryland, Baltimore, where he continued as faculty working on the Transplant Infectious Disease service as well as director of the Antimicrobial Stewardship program. He then moved to the VA Portland Healthcare System and Oregon Health and Science University to continue work on Antimicrobial Stewardship and Transplant Infectious Diseases, where he worked for 12 years until moving to Rush University in Chicago.
His work has focused on fungal infection in transplant recipients, including Cryptococcus gattii and moulds. Reducing antibiotic resistance with effective antibiotic stewardship in transplant recipients has also been a major focus. He has over 80 publications, 100 abstracts and 7 book chapters.
Dr. Nellore is Associate Professor of Infectious Diseases and Interim Director of the Immunocompromised Infectious Diseases Program at the University of Alabama at Birmingham. Her research interests relate to understanding immune responses to viral pathogens in the immunocompromised host.
Dr. Ushiro-Lumb is a Medical Virologist at the National Health Service Blood and Transplant, in the United Kingdom. Lead Clinical Microbiologist for Organ and Tissue Donation and Transplantation, and Clinical Director of the Virology Reference Laboratory. She is also part of the UK Health Security Agency Virus Reference Service in London. Member of various national and European committees on the quality and safety of blood, cells, tissues and organs for transfusion and transplantation and councilor of the International Society for Organ Donation and the Transplant Infectious Diseases section of the Transplantation Society.
Dr. Alissa Wright is a Clinical Associate Professor at the University of British Columbia (UBC). She is also the current Head of the Vancouver General Hospital (VGH) Division of Infectious Disease. She has established a Transplant Infectious Disease program for the province of British Columbia for both solid organ and hematopoietic stem cell transplant recipients. Her clinical responsibilities include the care of pre- and post-transplant patients at Vancouver General Hospital and St Paul’s Hospital in Vancouver. She is also a consultant for BC Transplant on infectious disease issues in organ donors and BC Cancer on infectious issues in cancer patients.
William Werbel, MD PhD, is an Assistant Professor of Medicine in the Division of Infectious Diseases, Section of Transplant/Oncology Infectious Diseases, at the Johns Hopkins University School of Medicine. He is also Associate Director of Epidemiology and Quantitative Sciences in the Johns Hopkins Transplant Research Center. Research efforts include serving as principal investigator of the Johns Hopkins national observational cohort of SARS-CoV-2 vaccine responses in immunocompromised persons, as well as the site principal investigator and protocol member for the NIH-funded COVID-19 Protection after Transplant (CPAT) trials. Other activities include membership and research within the multicenter HOPE in Action clinical trials group advancing the practice of HIV-to-HIV organ transplantation.
Lígia Camera Pierrotti, MD, PhD, is an ID physician graduated in State University of Campinas (Unicamp) in 1993. M.Sc and Ph.D. in Infectious Diseases at University of São Paulo, Brazil, in 2004. She is currently assistant physician at the Kidney Transplant Unit and leader member of Infectious Diseases on Immunocompromised Host Group at the Hospital das Clínicas, School of Medicine of the University of São Paulo (HCFMUSP). Ligia Pierrotti is Co-Chair of ID Committee of the Brazilian Association of Organ Transplantation (ABTO) and is permanent member of the Brazilian Standing Committee on Biosurveillance. Dra. Lígia is a member of Member ID Committee of National Transplant Program coordinated by Brazilian Ministry of Health and a member of TID/TTS. Her research has been directed towards epidemiology, prevention and management of infections in immunocompromised host, particularly solid organ transplant. Dra. Lígia is currently Associate Editor of Transplant International Journal.
Dr.Tan Thuan Tong MBBS, FAMS (Singapore), FRCP (UK), PhD(Lund) is a Senior Consultant and heads the Department of Infectious Diseases at the Singapore General Hospital. He has a special interest in immunocompromised hosts and transplantation. He is trained in Internal Medicine and Infectious Disease. He earned his PhD (Microbiology) in 2007. He is a part time senior consultant with Singapore’s Ministry of Health (MOH). He is also an ID panelist assisting the Health Science Authority (HSA) Medicines Advisory Committee on Covid therapeutics and vaccines evaluation. He chairs the VIFAP (vaccine injury financial assistance program) in MOH. Lastly, he is serving as a Co-Deputy Chair of the MOH Transplantation Services Advisory Committee.
Dr. Sishir Gang joined the department of Nephrology, Muljibhai Patel Urological hospital in 1997 and is the Chairman of the Department, since 2010. He holds a visiting faculty position at the Pramukhswami Medical college and Shri Krishna Hospital in Karamsad, Gujarat.
Dr. Gang received his MBBS and MD (general medicine; awarded Gold medal) from Baroda Medical College. His training in Nephrology, with degrees of DM and DNB, from the Christian Medical College and Hospital, Vellore and MGR University, Tamil Nadu. He has been awarded international fellowships from the International Society of Nephrology at the Arkansas Institute of Medical Sciences in Little Rock, USA, and from the International Society of Peritoneal Dialysis at the University of Missouri Medical School in Columbia, Missouri, USA.
His main area of interest is in renal transplantation. Dr. Gang has authored multiple original articles and book chapters. He has held several presentations at national and international conferences. He has mentored more than 50 Nephrologists.
Maddalena Giannella is an Associate Professor of Infectious Diseases at the Department of Medical and Surgical Sciences, University of Bologna and an Infectious Diseases consultant at IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy. Since 2016, she is member of the Executive Committee of the European Study Group of Bloodstream infection Endocarditis and Sepsis (ESGBIES) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). She is associate editor of Transplant International, the official journal of the European Society for Organ Transplantation (ESOT). She is author of 184 articles published on national and international peer reviewed journals, H-index 40 (Scopus source). The main research fields include antibiotic resistant infections, infections in solid organ transplant recipients, sepsis and bloodstream infections.
Organising secretary ISNCON 2013, 2017
Organising secretary: Kidney Transplant Update
Secretary Delhi Nephrology Society
Executive Member Indian Society of Nephrology and ISOT Publications:
Nassim Kamar, MD, PhD, is a Professor of Nephrology and is the Head of the Department of Nephrology and Organ Transplantation at Toulouse University Hospital, France. Dr. Kamar was graduated in 2002. He completed a 1-year postdoctoral fellowship in basic research at the Department of Nephrology, La Charité Hospital, Berlin, Germany. Dr. Kamar was awarded his Ph.D. degree in 2006. Dr. Kamar’s interests are viral infection, particularly hepatitis E virus, hepatitis C virus, cytomegalovirus, SARS-CoV-2, BK virus infections that develop after solid organ transplantation. Moreover, he is also interested in immunosuppression after transplantation. Dr. Kamar has published 660 papers in peer-review journals.
Marcelo Radisic, MD. is head of the Infectious Diseases department at the Instituto de Trasplante y Alta Complejidad in Buenos Aires, Argentina. This institution is the main transplantation center in Argentina, running kidney, kidney pancreas, liver and bone marrow transplantation programs. He´s been working in the Transplant Infectious Diseases field for the last 25 years, and is certified in his country in Internal Medicine and Infectious Diseases. He is a member of the Sociedad Argentina de Infectologia and Transplant Infectious Diseases society, being part of the council for the period 2021-2025
After graduation in 1990 (University of Zurich Medical School) Nicolas Mueller was Board certified in Internal Medicine in 1998 and in Infectious Diseases in 2004. In 2005 he was appointed senior lecturer at the University of Zurich and is a senior attending physician at the Division of Infectious Diseases and Hospital Epidemiology at the University Hospital Zurich.
His is involved in the routine care of transplanted patients. Basic research interests are viral infections in animal models of allo- and xenotransplantation, which he studied in the laboratory of Dr. Jay Fishman from 1998 to 2003. Currently, Dr. Mueller is involved in the Swiss Transplant Cohort Study on a local and national level and conducts epidemiological and translational studies in the field of transplant infectious diseases.
Arnaldo L Colombo, MD, PhD, FECMM, is a Professor of Medicine at Escola Paulista de Medicina-Federal University of Sao Paulo (UNIFESP) and Head of the Division of Infectious Diseases at the Hospital Sao Paulo-UNIFESP. Dr Colombo is President Elect of the International Society of Human and Animal Mycology-ISHAM, Senior Advisor of the Global Action Fund for Fungal Infections (GAFFI), and member of the International Council for supporting WHO in defining the Fungal Priority Pathogens List and characterize the global burden of antifungal resistance with Candida (GLASS-Candida). He coordinated and active participated of several multicenter epidemiologic studies to characterize the burden and natural history of fungal infections due to Candida, Aspergillus and Trichosporon in Brazil and Latin America. He coordinated or had active participation in several regional (LATAM and BRAZIL) and global guidelines (ISHAM-ECMM initiatives) for the clinical management of opportunistic fungal infections.
Marwan Mikheal Azar, MD, FAST, FIDSA is an Assistant Professor of Medicine (Infectious Diseases) and Laboratory Medicine at Yale University, the Fellowship Program Director for the Infectious Disease fellowship at Yale and co-director of the 2nd year Transplant infectious diseases/immunocompromised host specialty track. He is a past member of the Infectious Diseases Society of America Diagnostics committee, a current advisor to the Clinical and Laboratory Standards Institute fungal antifungal subcommittee and a current member of both the IDSA and the American Society of Transplantation Education committees. He recently chaired an AST-sponsored consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients.
Daniel Kaul MD is a professor of internal medicine in the division of infectious disease and the University of Michigan. He directs the transplant infectious disease service as well as the infectious disease training program. Dr. Kaul served as chair of the OPTN Disease Transmission Advisory Committee and currently serves on the ATC Program Committee. He has been the local principal investigator on numerous clinical trials of antiviral agents as well as investigator initiated trials.
Anton Peleg is a Professor of Infectious Diseases and Microbiology, NHMRC Practitioner Fellow and Director of the Department of Infectious Diseases at The Alfred Hospital and Monash University, Melbourne, VIC. He is Theme Leader for Infection and Immunity at Monash Academic Health Research and Translational Centre, and has recently been elected as a Fellow of the Australian Academy of Health and Medical Sciences.
He completed his infectious diseases clinical training in Australia in 2005 and then went to the USA for four years and worked at the Harvard-affiliated hospitals; Beth Israel Deaconess Medical Center and Massachusetts General Hospital. He completed a Masters of Public Health at Harvard School of Public Health, and also completed a PhD in Infectious Diseases and Microbiology with a focus on antimicrobial resistance (AMR) and genomics. He returned to Australia in 2010 as a clinician-scientist.
His research interests are in hospital-acquired infections, AMR and novel solutions, bacterial genomics, mechanisms of pathogenesis and infections in immunocompromised hosts. He is also an active clinician working in the area of hospital-acquired infections and transplant infectious diseases. He has received numerous national and international awards for his advanced research and contribution to Infectious Diseases and Microbiology.
Dr. Steven Pergam is an Associate Member in the Clinical Research and Vaccine and Infectious Diseases Division of the Fred Hutchinson Cancer Research Center; Associate Professor in the Division of Allergy & Infectious Diseases at the University of Washington; and the Director of Infection Prevention at the Seattle Cancer Care Alliance, in Seattle, WA. His current research interest focuses on the epidemiology of major transplant pathogens and on the development of novel prevention strategies for community and healthcare-associated infections in cancer and hematopoietic cell transplant patients.
Camille Nelson Kotton MD, FIDSA, FAST is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts. She was chair of The Infectious Disease Community of Practice of The American Society of Transplantation (2012-2018). From 2007-2013, she was the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her time as President include the development of international guidelines on CMV management after solid organ transplant, published in Transplantation (2010, 2013, 2018). She is the first transplant infectious disease specialist to be a councilor of The Transplantation Society (2020). Her clinical interests include vaccinations in transplant candidates and recipients, cytomegalovirus, zoonoses, and travel and tropical medicine in the transplant setting. She is a member of the USA CDC Advisory Committee on Immunization Practices (ACIP) and is involved in national decisions regarding COVID-19 and other vaccines.
Emily Blumberg, MD is a Transplant Infectious Diseases specialist and the Director of the Transplant Infectious Diseases Program and the Infectious Diseases Fellowship at the University of Pennsylvania. She is a Deputy Editor for the American Journal of Transplantation. She served as AST President from 2019-2020 and currently serves on its COVID-19 task force. Dr. Blumberg's academic interests are focused on infectious disease complications in transplant recipients and candidates. She is especially interested in donor derived infections and viral infections, including HIV, CMV, HCV and now COVID-19.
Transplant Infectious Disease
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6